| May 4, 2027 |
AMGN |
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta |
Trial Milestone |
Phase 3 |
| May 6, 2027 |
SLDB |
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) |
Trial Milestone |
Phase 1/Phase 2 |
| May 7, 2027 |
RYTM |
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment |
Trial Milestone |
Phase 1/Phase 2 |
| May 14, 2027 |
JNJ |
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Trial Milestone |
Phase 2/Phase 3 |
| May 15, 2027 |
LLY |
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
LLY |
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
ABBV |
Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
ABBV |
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults. |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
ABBV |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
REGN |
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH) |
Trial Milestone |
Phase 1/Phase 2 |
| May 15, 2027 |
AAPG |
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
IBRX |
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer |
Trial Milestone |
Phase 2 |
| May 15, 2027 |
MRNA |
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
ALKS |
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
ALKS |
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
XENE |
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
KLRA |
Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes |
Trial Milestone |
Phase 2 |
| May 15, 2027 |
LQDA |
A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag |
Trial Milestone |
Phase 4 |
| May 15, 2027 |
VRCA |
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
IMVT |
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease |
Trial Milestone |
Phase 2 |
| May 15, 2027 |
RCUS |
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer |
Trial Milestone |
Phase 2 |
| May 15, 2027 |
RCUS |
Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
GKOS |
Travoprost Intraocular Implant + iStent Infinite |
Trial Milestone |
Phase 4 |
| May 15, 2027 |
GENB |
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD |
Trial Milestone |
Phase 1 |
| May 15, 2027 |
VOR |
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
OKYO |
Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP). |
Trial Milestone |
Phase 3 |
| May 15, 2027 |
IRON |
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia |
Trial Milestone |
Phase 1/Phase 2 |
| May 15, 2027 |
XNCR |
Study of XmAb412 in Healthy Participants |
Trial Milestone |
Phase 1 |
| May 18, 2027 |
SNY |
A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration |
Trial Milestone |
Phase 1/Phase 2 |
| May 18, 2027 |
APLM |
A Study of APL-10456-Vaccine |
Trial Milestone |
EARLY_Phase 1 |
| May 20, 2027 |
REGN |
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) |
Trial Milestone |
Phase 2 |
| May 20, 2027 |
BIIB |
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis |
Trial Milestone |
Phase 3 |
| May 25, 2027 |
IBRX |
Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma |
Trial Milestone |
Phase 2 |
| May 26, 2027 |
BIIB |
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS) |
Trial Milestone |
Phase 4 |
| May 26, 2027 |
FDMT |
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia |
Trial Milestone |
Phase 1 |
| May 28, 2027 |
ALNY |
A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus |
Trial Milestone |
Phase 2 |
| May 30, 2027 |
OLMA |
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors |
Trial Milestone |
Phase 1 |
| May 30, 2027 |
ACRV |
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma |
Trial Milestone |
Phase 2 |
| May 31, 2027 |
AZN |
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation |
Trial Milestone |
Phase 4 |
| May 31, 2027 |
JNJ |
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib |
Trial Milestone |
Phase 2 |
| May 31, 2027 |
ONC |
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies |
Trial Milestone |
Phase 1 |
| May 31, 2027 |
BIIB |
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) |
Trial Milestone |
Phase 3 |
| May 31, 2027 |
EXEL |
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors |
Trial Milestone |
Phase 1 |
| May 31, 2027 |
RVMD |
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS |
Trial Milestone |
Phase 1/Phase 2 |
| May 31, 2027 |
INBS |
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection |
Trial Milestone |
Phase 1 |
| May 31, 2027 |
SRPT |
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) |
Trial Milestone |
Phase 3 |